Effects of adenosine and isoprenaline in left atria from both neonatal and middle-aged noninsulin-dependent diabetic rat models

General Pharmacology

Volumn 29, Issue 4, 1997, Pages 517-522

  Gür, Serap ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Adenosine; antiadrenergic effect; Direct; Middle aged; Neonatal; Noninsulin dependent diabetes mellitus (NIDDM)

Indexed keywords

ADENOSINE; ISOPRENALINE;

ADULT; AGE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; HEART LEFT ATRIUM; INOTROPISM; MALE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERSENSITIVITY;

EID: 0343247763     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00569-1     Document Type: Article

References (43)

1. Bardenheuer H., Schrader J. Relationship between myocardial oxygen consumption, coronary flow, and adenosine relase in an improved isolated working heart preparation of guinea pigs. Circ. Res. 51:1983;263-271.
2. Bardenheuer H., Schrader J. Supply-to-demand ratio for oxgen determines formation of adenosine by the heart. Am. J. Physiol. 250:1986;H173-H180.
3. Belardinelli L. B., Linden J., Berne R. M. The cardiac effects of adenosine. Prog. Cardiovasc. Dis. 32:1989;93-97.
4. Belardinelli L., Shryock J. Does adenosine function as a retaliatory metabolite in the heart? News Pharmac. Sci. 7:1992;52-56.
5. Bitar M. S., Koulu M., Rapoport S. I., Linnoila M. Adrenal catecholamine metabolism and myocardial adrenergic receptors in streptozotocin diabetic rats. Biochem. Pharmac. 36:1987;1011-1016.
6. Blondel O., Bailbe D., Portha B. Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin. evidence for reversal following phlorizin treatment Metabolism. 39:1990;787-793.
7. Burnstock G., Meghji P. The effect of adenyl compounds on the rat heart. Br. J. Pharmac. 79:1983;211-218.
8. Dobson J. G., Fenton R. A. Adenosine inhibition of beta-adrenergic induced responses in the aged hearts. Am. J. Physiol. 265:1993;H494-H503.
9. Dobson J. G. Jr., Fenton R. A., Romano F. D. The antiadrenergic actions of adenosine in the heart. Gerlach E., Becher B. F. Topics and Perspectives in Adenosine Research. 1987;356-368 Springer-Verlag, New York.
10. Dobson J. G., Fenton R. A., Romano F. D. Increased myocardial adenosine production and reduction of beta-adrenergic contractile response in aged hearts. Circ. Res. 66:1990;1381-1390.
11. Durante W., Sunahara F. A., Sen A. K. Alterations in atrial reactivity in a strain of spontaneously diabetic rats. Br. J. Pharmac. 97:1989;1137-1144.
12. Fantus I. G, Chayoth R., O' Dea L., Marliss E. B, Yale J. F., Grose M. Insulin binding and glucose transport in adipocytes in neonatal streptozotocin-injected rat model of diabetes mellitus. Diabetes. 36:1987;654-660.
13. Fenton R. A., Tsimikas S., Dobson J. G. Jr. Influence of beta- adrenergic stimulation and contraction frequency on rat heart interstitial adenosine. Circ. Res. 66:1990;457-468.
14. Foy J. M., Lucas P. D. Comparison between spontaneously beating atria from control and streptozotocin-diabetic rats. J. Pharm. Pharmac. 30:1978;558-562.
15. 1 adenosine receptor agonist. J. Biol. Chem. 262:1987;15702-15707.
16. Hamby R. I., Zoneraich S., Sherman L. Diabetic cardiomyopathy. J. Am. Med. Assoc. 229:1974;1749-1754.
17. 2, and adenosine formation in hearts stimulated with inotropic agents. Can. J. Physiol. Pharmac. 68:1990;110-118.
18. Hei Y. J., Diamond J., McNeill J. Alterations of G protein function in cardiac tissues from streptozotocin-induced chronic diabetic rats. Gen. Pharmac. 23:1992;889-896.
19. Hoffman B. B., Dall'aglio E., Hollenbeck C., Chang H., Reaven G. M. Suppression of free fatty acids and triglycerides in normal and hypertriglyceridemic rats by the adenosine receptor agonist phenylisopropyladenosine. J. Pharmac. Exp. Ther. 239:1986;715-718.
20. Hughes S., Stone T. Inhibition by purines of the inotropic action of isoprenaline in rat atria. Br. J. Pharmac. 80:1983;149-153.
21. Ingebretsen C. G., Moreau P., Hawelu-Johnson C., Ingebretsen W. R. Jr. Performance of diabetic rat hearts. effect of anoxia and increased work Am J. Physiol. 239:1980;H614-H620.
22. Karl I. E, Gavin J. R., Levy J. Effect of insulin on glucose utilization in epictrochlearis muscle of rats with streptozotocin induced NIDDM. Diabetes. 39:1990;1106-1115.
23. Law W. R., McLane M. P., Raymond R. M. Adenosine is required for myocardial insulin responsiveness in vivo. Diabetes. 37:1988;842-845.
24. Liang B. T. Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes. coupling to modulation of contractility and adenylyl cyclase activity and identification by direct radioligand binding J.Pharmac. Exp. Ther. 249:1989;775-784.
25. 1-adenosine receptor-mediated inhibition of cardiac myocyte contractility and adenylate cyclase activity. Circ. Res. 67:1990;406-414.
26. Paulson D. J., Light K. E. Elevation of serum and ventricular norepinephrine content in the diabetic rat. Res. Commun. Chem. Pathol. Pharmac. 33:1981;559-562.
27. Portha B., Picon L., Rosselin G. Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia. 17:1979;371-377.
28. Reaven G. M., Chang H., Hoffman B. B. Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozotocin-induced diabetes. Diabetes. 37:1988;28-32.
29. Regan T. J., Lyons M. M., Ahmed S. S., Levinson G. E., Oldwurtel H. A., Ahmed M. R., Haider B. Evidence for cardiomyopathy in familial diabetes mellitus. J. Clin. Invest. 60:1977;885-899.
30. Romano F. D., Kopp S. J., Daar J. T., Smith C. A. The antiadrenergic effect of cyclopentyladenosine on myocardial contractility is reduced in vivo in diabetic rats. Can. J. Physiol. Pharmac. 72:1994;1245-1255.
31. Sato N., Hashimoto H., Takiguchi Y., Nakashima M. Altered responsiveness to sympathetic nerve stimulation and agonists of isolated left atria of diabetic rats. no evidence for involvement of hypothyroidism J. Pharmac. Exp. Ther. 248:1989;367-371.
32. Schaffer S. W., Allo S., Punna S., White T. Defective response to cAMP-dependent protein kinase in non-insulin-dependent diabetic heart. Am. J. Physiol. 261:1991;E369-E376.
33. Schaffer S. W., Seyed-Mozaffari M., Cutcliff C. R., Wilson G. L. Postreceptor myocardial metabolic defect in a rat model of non-insulin-dependent diabetes mellitus. Diabetes. 35:1986;593-597.
34. Schaffer S. W., Tan B. H., Wilson G. L. Development of a cardiomyopathy in a model of noninsulin-dependent diabetes. Am. J. Physiol. 246:1985;H179-H185.
35. Schaffer S. W., Wilson G. L. Insulin resistance and mechanical dysfunction in hearts of Wistar rats with streptozotocin-induced non- insulin dependent diabetes mellitus. Diabetologia. 36:1993;195-199.
36. Shapiro S. W., Leatherdal B. A., Coyne M. E. Prospective study of heart disease in untreated maturity of diabetics. Br. Heart J. 44:1980;342-348.
37. Shryoch J., Patel A., Belardinelli L., Linden J. Down regulation and desensitization of A1- adenosine receptors in embryonic chick heart. Am. J. Physiol. 256:1989;H321-H327.
38. Sunagawa R. K., Murakami K., Mimura G., Sakanashi M. Effects of adrenergic drugs on isolated and perfused hearts of streptozotocin induced diabetic rats. Jpn. J. Pharmac. 44:1987;233-240.
39. Trent D. F., Fletcher D. J., May J. M., Bonner-Weir S., Weir G. C. Abnormal islet and adiposite function in young β-cell deficent rats with near normoglycemia. Diabetes. 33:1984;170-175.
40. Vadlamudi R. V. S. V., McNeill J. H. Effect of experimental diabetes on isolated rat heart responsiveness to isoproterenol. Can J. Physiol. Pharmac. 62:1984;124-131.
41. Vary T. C., Angelakos E. T., Schaffer S. W. Relationship between adenine nucleotide metabolism and irreversible ischemic tissue damage in isolated perfused rat heart. Circ. Res. 45:1979;218-225.
42. Warner E. L., Gallasso F., Thompson C. I., Belloni F. L. Vasodilative and anti-adrenergic effects of adenosine in diabetic rat hearts. Can. J. Physiol. Pharmac. 70:1992;13-19.
43. Weir G. C., Clore E. E., Zmachinsky C. J., Bonner-Weir S. Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes. 34:1981;64-69.